BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 10548882)

  • 1. Enzymology and biology of CaaX protein prenylation.
    Fu HW; Casey PJ
    Recent Prog Horm Res; 1999; 54():315-42; discussion 342-3. PubMed ID: 10548882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody.
    Baron R; Fourcade E; Lajoie-Mazenc I; Allal C; Couderc B; Barbaras R; Favre G; Faye JC; Pradines A
    Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11626-31. PubMed ID: 11027361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of protein farnesyltransferase to a geranylgeranyltransferase.
    Terry KL; Casey PJ; Beese LS
    Biochemistry; 2006 Aug; 45(32):9746-55. PubMed ID: 16893176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-terminal proteolysis of prenylated proteins in trypanosomatids and RNA interference of enzymes required for the post-translational processing pathway of farnesylated proteins.
    Gillespie JR; Yokoyama K; Lu K; Eastman RT; Bollinger JG; Van Voorhis WC; Gelb MH; Buckner FS
    Mol Biochem Parasitol; 2007 Jun; 153(2):115-24. PubMed ID: 17397944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnesylation and proteolysis are sequential, but distinct steps in the CaaX box modification pathway.
    Farh L; Mitchell DA; Deschenes RJ
    Arch Biochem Biophys; 1995 Apr; 318(1):113-21. PubMed ID: 7726551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity.
    Reid TS; Terry KL; Casey PJ; Beese LS
    J Mol Biol; 2004 Oct; 343(2):417-33. PubMed ID: 15451670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using inhibitors of prenylation to block localization and transforming activity.
    Berzat AC; Brady DC; Fiordalisi JJ; Cox AD
    Methods Enzymol; 2006; 407():575-97. PubMed ID: 16757354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein prenylation: molecular mechanisms and functional consequences.
    Zhang FL; Casey PJ
    Annu Rev Biochem; 1996; 65():241-69. PubMed ID: 8811180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disrupting the transforming activity of shrimp ras(Q(61)K) by deleting the CAAX box at the C-terminus.
    Huang CF; Chen CH; Chuang NN
    J Exp Zool; 2001 Jun; 289(7):441-8. PubMed ID: 11351331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and structural studies with prenyl diphosphate analogues provide insights into isoprenoid recognition by protein farnesyl transferase.
    Turek-Etienne TC; Strickland CL; Distefano MD
    Biochemistry; 2003 Apr; 42(13):3716-24. PubMed ID: 12667062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate characterization of the Saccharomyces cerevisiae protein farnesyltransferase and type-I protein geranylgeranyltransferase.
    Caplin BE; Hettich LA; Marshall MS
    Biochim Biophys Acta; 1994 Mar; 1205(1):39-48. PubMed ID: 8142482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prenylation of proteins.
    Sinensky M; Lutz RJ
    Bioessays; 1992 Jan; 14(1):25-31. PubMed ID: 1546978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Geranylgeranyltransferase Type 1 as a Target in Cancer.
    Ullah N; Mansha M; Casey PJ
    Curr Cancer Drug Targets; 2016; 16(7):563-71. PubMed ID: 26648485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras farnesyltransferase inhibition: a novel and safe approach for cancer chemotherapy.
    Nammi S; Lodagala DS
    Acta Pharmacol Sin; 2000 May; 21(5):396-404. PubMed ID: 11324435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
    Lobell RB; Omer CA; Abrams MT; Bhimnathwala HG; Brucker MJ; Buser CA; Davide JP; deSolms SJ; Dinsmore CJ; Ellis-Hutchings MS; Kral AM; Liu D; Lumma WC; Machotka SV; Rands E; Williams TM; Graham SL; Hartman GD; Oliff AI; Heimbrook DC; Kohl NE
    Cancer Res; 2001 Dec; 61(24):8758-68. PubMed ID: 11751396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein prenylation in an insect cell-free protein synthesis system and identification of products by mass spectrometry.
    Suzuki T; Ito M; Ezure T; Shikata M; Ando E; Utsumi T; Tsunasawa S; Nishimura O
    Proteomics; 2007 Jun; 7(12):1942-50. PubMed ID: 17514686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the development of farnesyltransferase inhibitors: substrate recognition by protein farnesyltransferase.
    Yang W; Del Villar K; Urano J; Mitsuzawa H; Tamanoi F
    J Cell Biochem Suppl; 1997; 27():12-9. PubMed ID: 9591188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression cloning of a novel farnesylated protein, RDJ2, encoding a DnaJ protein homologue.
    Andres DA; Shao H; Crick DC; Finlin BS
    Arch Biochem Biophys; 1997 Oct; 346(1):113-24. PubMed ID: 9328291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of protein prenylation in vitro and in vivo using functionalized phosphoisoprenoids.
    Nguyen UT; Wu Y; Goodall A; Alexandrov K
    Curr Protoc Protein Sci; 2010 Nov; Chapter 14():Unit14.3. PubMed ID: 21104984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic incorporation of orthogonally reactive prenylazide groups into peptides using geranylazide diphosphate via protein farnesyltransferase: implications for selective protein labeling.
    Rose MW; Xu J; Kale TA; O'Doherty G; Barany G; Distefano MD
    Biopolymers; 2005; 80(2-3):164-71. PubMed ID: 15810014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.